Annual EBITDA
-$8.58 M
-$19.50 K-0.23%
December 31, 2023
Summary
- As of February 12, 2025, QNRX annual EBITDA is -$8.58 million, with the most recent change of -$19.50 thousand (-0.23%) on December 31, 2023.
- During the last 3 years, QNRX annual EBITDA has fallen by -$6.64 million (-341.44%).
- QNRX annual EBITDA is now -457.44% below its all-time high of -$1.54 million, reached on December 31, 2019.
Performance
QNRX EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBITDA
-$2.50 M
-$390.90 K-18.51%
September 30, 2024
Summary
- As of February 12, 2025, QNRX quarterly EBITDA is -$2.50 million, with the most recent change of -$390.90 thousand (-18.51%) on September 30, 2024.
- Over the past year, QNRX quarterly EBITDA has dropped by -$69.70 thousand (-2.86%).
- QNRX quarterly EBITDA is now -728.53% below its all-time high of -$302.10 thousand, reached on September 30, 2020.
Performance
QNRX Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBITDA
-$8.55 M
-$403.80 K-4.96%
September 30, 2024
Summary
- As of February 12, 2025, QNRX TTM EBITDA is -$8.55 million, with the most recent change of -$403.80 thousand (-4.96%) on September 30, 2024.
- Over the past year, QNRX TTM EBITDA has dropped by -$281.80 thousand (-3.41%).
- QNRX TTM EBITDA is now -2341.03% below its all-time high of -$350.20 thousand, reached on June 30, 2020.
Performance
QNRX TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
QNRX EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -0.2% | -2.9% | -3.4% |
| 3 y3 years | -341.4% | +9.0% | +11.5% |
| 5 y5 years | -457.4% | +9.0% | +11.5% |
QNRX EBITDA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -0.2% | +57.6% | -66.9% | +77.7% | -5.0% | +57.8% |
| 5 y | 5-year | -457.4% | +57.6% | -728.5% | +77.7% | -2341.0% | +57.8% |
| alltime | all time | -457.4% | +57.6% | -728.5% | +77.7% | -2341.0% | +57.8% |
Quoin Pharmaceuticals EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$2.50 M(+18.5%) | -$8.55 M(+5.0%) |
| Jun 2024 | - | -$2.11 M(-13.2%) | -$8.14 M(-1.5%) |
| Mar 2024 | - | -$2.43 M(+62.2%) | -$8.27 M(-3.7%) |
| Dec 2023 | -$8.58 M(+0.2%) | -$1.50 M(-28.5%) | -$8.58 M(-5.2%) |
| Sep 2023 | - | -$2.10 M(-6.0%) | -$9.06 M(-2.1%) |
| Jun 2023 | - | -$2.23 M(-18.7%) | -$9.25 M(-4.2%) |
| Mar 2023 | - | -$2.75 M(+39.2%) | -$9.66 M(+6.6%) |
| Dec 2022 | -$8.56 M | -$1.97 M(-13.7%) | -$9.06 M(-50.5%) |
| Sep 2022 | - | -$2.29 M(-13.3%) | -$18.30 M(+6.8%) |
| Jun 2022 | - | -$2.64 M(+22.9%) | -$17.14 M(-7.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2022 | - | -$2.15 M(-80.8%) | -$18.61 M(-8.2%) |
| Dec 2021 | -$20.27 M(+942.4%) | - | - |
| Dec 2021 | - | -$11.22 M(+892.6%) | -$20.27 M(+102.8%) |
| Sep 2021 | - | -$1.13 M(-72.5%) | -$10.00 M(+9.0%) |
| Jun 2021 | - | -$4.11 M(+7.8%) | -$9.17 M(+69.5%) |
| Mar 2021 | - | -$3.81 M(+303.3%) | -$5.41 M(+238.6%) |
| Dec 2020 | -$1.94 M(+26.3%) | - | - |
| Dec 2020 | - | -$945.30 K(+212.9%) | -$1.60 M(+144.9%) |
| Sep 2020 | - | -$302.10 K(-13.7%) | -$652.30 K(+86.3%) |
| Jun 2020 | - | -$350.20 K | -$350.20 K |
| Dec 2019 | -$1.54 M | - | - |
FAQ
- What is Quoin Pharmaceuticals annual EBITDA?
- What is the all time high annual EBITDA for Quoin Pharmaceuticals?
- What is Quoin Pharmaceuticals annual EBITDA year-on-year change?
- What is Quoin Pharmaceuticals quarterly EBITDA?
- What is the all time high quarterly EBITDA for Quoin Pharmaceuticals?
- What is Quoin Pharmaceuticals quarterly EBITDA year-on-year change?
- What is Quoin Pharmaceuticals TTM EBITDA?
- What is the all time high TTM EBITDA for Quoin Pharmaceuticals?
- What is Quoin Pharmaceuticals TTM EBITDA year-on-year change?
What is Quoin Pharmaceuticals annual EBITDA?
The current annual EBITDA of QNRX is -$8.58 M
What is the all time high annual EBITDA for Quoin Pharmaceuticals?
Quoin Pharmaceuticals all-time high annual EBITDA is -$1.54 M
What is Quoin Pharmaceuticals annual EBITDA year-on-year change?
Over the past year, QNRX annual EBITDA has changed by -$19.50 K (-0.23%)
What is Quoin Pharmaceuticals quarterly EBITDA?
The current quarterly EBITDA of QNRX is -$2.50 M
What is the all time high quarterly EBITDA for Quoin Pharmaceuticals?
Quoin Pharmaceuticals all-time high quarterly EBITDA is -$302.10 K
What is Quoin Pharmaceuticals quarterly EBITDA year-on-year change?
Over the past year, QNRX quarterly EBITDA has changed by -$69.70 K (-2.86%)
What is Quoin Pharmaceuticals TTM EBITDA?
The current TTM EBITDA of QNRX is -$8.55 M
What is the all time high TTM EBITDA for Quoin Pharmaceuticals?
Quoin Pharmaceuticals all-time high TTM EBITDA is -$350.20 K
What is Quoin Pharmaceuticals TTM EBITDA year-on-year change?
Over the past year, QNRX TTM EBITDA has changed by -$281.80 K (-3.41%)